Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
EdematousSynovitisForeign Body ReactionOsteolysis
Interventions
DRUG

Placebo

Two capsules taken twice daily with meals

DRUG

Apatone®B

Two capsules taken twice daily with meals

Trial Locations (1)

44310

Summa Health System, Akron

Sponsors
All Listed Sponsors
collaborator

Summa Health System

OTHER

collaborator

Crystal Clinic Orthopaedic Center LLC

OTHER

lead

IC-MedTech Corporation

INDUSTRY

NCT01272830 - Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements | Biotech Hunter | Biotech Hunter